a b s t r a c t
Highly resistant tumor cells are hard to treat at low doses of plasma. Therefore, researchers have gained more attention to development of enhancers for plasma therapy. Some enhancers could improve the efficacy of plasma towards selectivity of cancer cells damage. In this dataset, we report the application of low doses of PEG-coated gold nanoparticles with addition of plasma treatment. This data consists of the effect of PEG-coated GNP and cold plasma on two solid tumor cell lines T98G glioblastoma and A549 lung adenocarcinoma. Cell proliferation, frequency of cancer stem cell population studies by this co-treatment was reported. Finally, we included in this dataset the effect of co-treatment in vivo, using tumor xenograft nude mice models. The data supplied in this article supports the accompanying publication "Low doses of PEG-coated gold nanoparticles sensitize solid tumors to cold plasma by blocking the PI3K/AKT-driven signaling axis to suppress cellular transformation by inhibiting growth and EMT" (N. K. Kaushik, N. Kaushik 
Value of the data
This data will be helpful for the scientific community that evaluates various nanomaterials as a cancer targeted therapy for improving existing cancer therapeutic approaches.
This data allows the scientific community to elucidate the mechanistic basis of gold nanoparticles and plasma-induced cell destruction.
This data confirmed that cancer stem cell populations could be suppressed through GNP and plasma co-treatment.
This data elucidates the theses co-treatments have potential to inhibit tumor cell growth in vivo also.
Data
We applied the combination approach to inhibit solid tumor growth using gold nanoparticles and air micro dielectric barrier discharge plasma. In this data, T98G and A549 cells decreased cell proliferation in dose and incubation time-dependent manner ( Figs. 1 and 2 ). Next, we utilized this effect on CSC maintenance, there was a decrease observed in frequency of stem cell population (Fig. 3 ). This dataset also depicts the analysis of tumor size in vivo (Fig. 4) . Tumor growth was significantly inhibited in treated tumors as compared to untreated tumors.
Experimental design, materials and methods

Cell proliferation assay
Cell viability was determined using MTT assays in GNP plus plasma co-treated solid cancer cells. The colorimetric MTT test evaluates cell metabolic activity based on the capability of mitochondrial succinate reductase to convert a yellow-colored dye (MTT) to purple formazan in living cells. The color density of the purple-colored formazan crystals is directly proportional to the metabolic activity of the cells. MTT assays were performed according to previously reported methods [2, 3] . 
Quantification of cell death
For quantification of cell death, cells were stained with propidium iodide (PI). The cells were harvested using trypsinization, washed in phosphate-buffered saline and then incubated in PI (50 ng/mL) for 5 min at room temperature. Then immediately analyzed using BD FACSVerse using the FACS suite software.
Limiting dilution assay
Treated with vehicle and combination (GNP þplasma) glioma-like stem cells were enzymatically dissociated into single-cell suspensions, plated into 96-well plates with various seeding densities (0, 1, 3, 5, 10, 15, 20 cells per well). After cell seeding, the plate incubated at 37°C for 10-15 days. On day 15, each well was observed under a microscope for the determination of individual tumor cell sphere formation. Positive wells with sphere formation were counted and log fraction of wells without spheres was plotted, and data was calculated using the Extreme Limiting Dilution Analysis (http:// bioinf.wehi.edu.au/software/elda/index.html).
Tumor volume measurement
U87 Glioma cells (10 6 cells) in 200 μl PBS were injected subcutaneously into right hind flan of BALB/c female nude mice. Incomplete DMEM media is treated with 10 min dielectric barrier discharge (DBD) plasma exposure to prepare plasma-activated media (PAM) [1] . Mice were treated via subcutaneous injection into tumors with 0.5 mg/kg body weight of GNP in PBS and 200 μl PAM in same group. PAM is injected four times at every next days after single dose of GNP treatment. Treated group describes treatment with both GNP and PAM. Tumor size was measured with a caliper (calculated volume ¼shortest diameter 2 Â longest diameter/2) with 3 day intervals. This study was reviewed and 
